Good 5-year postoperative outcomes after facet fusion using a percutaneous pedicle screw system for degenerative lumbar spondylolisthesis

被引:0
作者
Tomohiro Miyashita
Hiromi Ataka
Kei Kato
Takaaki Tanno
机构
[1] Matsudo City General Hospital,Spine Center
[2] Matsudo Orthopaedic Hospital,Spine Center
来源
Neurosurgical Review | 2022年 / 45卷
关键词
Facet joint fusion; In situ fusion; Fusion rate; Adjacent segment disease; Nonunion; Posterolateral fusion;
D O I
暂无
中图分类号
学科分类号
摘要
Many authors have reported no significant differences in clinical outcomes between posterolateral fusion (PLF) and interbody fusion, as well as satisfactory long-term outcomes after PLF. Facet fusion (FF), a minimally invasive evolution of PLF, has also resulted in good clinical outcomes. This study aimed to assess the clinical outcomes 5 years after FF for degenerative lumbar spondylolisthesis (DLS) and determine whether good clinical outcomes were maintained after FF. Records of 115 patients who underwent FF for single-level DLS with at least 5 years of follow-up were retrospectively studied. The therapeutic effectiveness of FF was assessed as a clinical outcome using the Japanese Orthopaedic Association Back Pain Evaluation Questionnaire (JOABPEQ), the Roland-Morris Disability Questionnaire (RMDQ), and the visual analogue scale (VAS) preoperatively and at 1 and 5 years postoperatively. Computed tomography was performed for fusion confirmation. The revision surgery rate was also evaluated. The JOABPEQ category scores demonstrated therapeutic effectiveness in 81.7% of patients at 1 year postoperatively and 81.4% of patients at 5 years postoperatively for low back pain; the corresponding proportions for walking ability were 93.8% and 86.6%, respectively. There were no significant differences in therapeutic effectiveness at 1 and 5 years postoperatively for any category, including the RMDQ and VAS scores. The fusion rate was 90.4% at the final follow-up. Four patients required revision surgery for adjacent segment disease 1–5 years after the first surgery (revision surgery rate, 3.5%). Good clinical outcomes were maintained 5 years after FF, and FF had an extremely low revision surgery rate.
引用
收藏
页码:2269 / 2276
页数:7
相关论文
共 120 条
  • [1] Colman MW(2019)Perioperative effects associated with the surgical treatment of degenerative spondylolisthesis: interbody versus no interbody Clin Spine Surg 32 E71-E77
  • [2] Baronne LM(2016)Comparison of clinical and radiological results of posterolateral fusion and posterior lumbar interbody fusion in the treatment of L4 degenerative lumbar spondylolisthesis Asian Spine J 10 143-152
  • [3] Brodke DS(2008)The positive effect of posterolateral lumbar spinal fusion is preserved at long-term follow-up: a RCT with 11–13 year follow-up Eur Spine J 17 272-280
  • [4] Woodbury AM(2002)Clinical results of posterolateral fusion for degenerative lumbar spinal diseases: a follow-up study of more than 10 years J Orthop Sci 7 317-324
  • [5] Annis P(2012)Lumbar instrumented posterolateral fusion in spondylolisthetic and failed back patients: a long-term follow-up study spanning 11–13 years Eur Spine J 21 2140-2148
  • [6] Lawrence BD(2020)Potential significance of facet joint fusion or posteromedial fusion observed on CT imaging following attempted posterolateral or posterior interbody fusion Spine J 20 337-343
  • [7] Kuraishi S(2020)Modified facet joint fusion for lumbar degenerative disease: case series of a fusion technique, clinical outcomes, and fusion rate in 491 patients Oper Neurosurg (Hagerstown) 19 255-263
  • [8] Takahashi J(2021)Good clinical outcomes in nonunion cases after facet fusion with a percutaneous pedicle screw system for degenerative lumbar spondylolisthesis Neurosurg Rev 44 2847-2855
  • [9] Mukaiyama K(2020)Minimum clinically important difference of major patient-reported outcome measures in patients undergoing decompression surgery for lumbar spinal stenosis Clin Neurol Neurosurg 196 598-604
  • [10] Shimizu M(2011)Utility of minimum clinically important difference in assessing pain, disability, and health state after transforaminal lumbar interbody fusion for degenerative lumbar spondylolisthesis J Neurosurg Spine 14 1813-1823